Placebo for Atogepant clinical trials
4 indexed studies · 1 currently recruiting
- RecruitingPHASE3
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
This study is testing a new tablet called atogepant to see if it can help prevent chronic migraines in young people aged 12 to 17. We want to know if it's safe and if it works better than a dummy pill.
For: Chronic MigraineUnited States · Canada · Denmark - Active not recruitingPHASE3
Comparative Study of Oral Atogepant Versus Oral Topiramate to Assess Adverse Events in Adult Participants With Migraine
This study compares two medicines, atogepant and topiramate, for preventing migraine headaches. Researchers want to see which medicine causes fewer side effects in adults with migraines. It involves taking pills and having regular check-ups over a long period.
For: MigraineAustria · Belgium · Canada - Active not recruitingPHASE3
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
This study is testing a tablet called atogepant for treating migraine attacks. It aims to see if it's safe and effective at stopping migraines quickly. Atogepant is already approved for preventing migraines. Around 1300 adults aged 18-75 will take part worldwide.
For: MigraineBelgium · China · Czechia - Active not recruitingPHASE3
Study of Oral Atogepant to Assess Adverse Events and Change in Disease Activity in Adult Participants With Menstrual Migraine
This study is testing a new medicine, atogepant, to see if it can help prevent menstrual migraines. Researchers will see how well it works and if it has any side effects, compared to a dummy pill.
For: Menstrual Migraine (MM)China · Czechia · Germany